Literature DB >> 15991281

Expression and significance of tumor-related genes in HCC.

Zi-Li Lü1, Dian-Zhong Luo, Jian-Ming Wen.   

Abstract

AIM: To investigate the expression and clinical significance of DEK, cyclin D1, insulin-like growth factor II (IGF-II), glypican 3 (GPC3), ribosomal phosphoprotein 0 (rpP0) mRNA in hepatocellular carcinoma (HCC) and its paraneoplastic tissues.
METHODS: The expression of mRNAs of DEK, cyclin D1, IGF-II, GPC3 and rpP0 mRNA was detected in HCC and its paraneoplastic tissues by multiplex RT-PCR.
RESULTS: By the simplex RT-PCR, the overexpression of mRNAs of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNA in HCC and its paraneoplastic tissues was 78.1%, 87.5%, 87.5%, 75.0%, 81.3% and 15.6%, 40.6%, 37.5%, 21.9%, 31.3% respectively (P<0.05). By the multiplex RT-PCR, at least one of the mRNAs was detected in all HCC samples and in 75.0% of paraneoplastic samples (P>0.05). However, all these five mRNAs were found in 68.8% of HCC samples, but only in 9.4% of paraneoplastic tissues (P<0.05). The positive expression of mRNAs of DEK, cyclin D1, IGF-II, GPC3, rpP0 in well- and poorly-differentiated HCC was 89.0%, 66.7%, 66.7%, 66.7%, 77.8% and 73.9%, 95.7%, 95.7%, 95.7%, 82.6%, respectively (P>0.05). The expression of these genes in HCCs with alpha-feto protein (AFP) negative and positive was 90.0%, 80.0%, 90.0%, 90.0%, 90.0% and 72.7%, 86.3%, 77.3%, 90.9%, 68.2% respectively (P>0.05).
CONCLUSION: The expression of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNA in HCC is much higher in HCC than in its paraneoplastic tissues. Multiplex RT-PCR assay is an effective, sensitive, accurate, and cost-effective diagnostic method of HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991281      PMCID: PMC4504884          DOI: 10.3748/wjg.v11.i25.3850

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.

Authors:  S S Murthy; T Shen; A De Rienzo; W C Lee; P C Ferriola; S C Jhanwar; B T Mossman; J Filmus; J R Testa
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

2.  The RNA interacting domain but not the protein interacting domain is highly conserved in ribosomal protein P0.

Authors:  M A Rodríguez-Gabriel; M Remacha; J P Ballesta
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

3.  Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

Authors:  H Azechi; N Nishida; Y Fukuda; T Nishimura; M Minata; H Katsuma; M Kuno; T Ito; T Komeda; R Kita; R Takahashi; K Nakao
Journal:  Oncology       Date:  2001       Impact factor: 2.935

4.  Glypican-3 expression is silenced in human breast cancer.

Authors:  Y Y Xiang; V Ladeda; J Filmus
Journal:  Oncogene       Date:  2001-11-01       Impact factor: 9.867

5.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

6.  Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia.

Authors:  Tetsuo Maeda; Satoru Kosugi; Hidetoshi Ujiie; Kazuoki Osumi; Takashi Fukui; Hitoshi Yoshida; Hirokazu Kashiwagi; Jun Ishikawa; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

7.  Mouse models to study the interaction of risk factors for human liver cancer.

Authors:  Stewart Sell
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

8.  Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.

Authors:  Uma Raju; Eiko Nakata; Kathy A Mason; K Kian Ang; Luka Milas
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  Glypican-3 is overexpressed in human hepatocellular carcinoma.

Authors:  Young Kwan Sung; Sun Young Hwang; Mi Kyung Park; Mohammad Farooq; In Sook Han; Han Ik Bae; Jung-Chul Kim; Moonkyu Kim
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

10.  Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.

Authors:  K Jirström; A Ringberg; M Fernö; L Anagnostaki; G Landberg
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  17 in total

1.  High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Authors:  Guoliang Liu; Xiaodong Huang; Xiaopeng Cui; Jing Zhang; Lixian Wei; Runzhou Ni; Cuihua Lu
Journal:  Med Oncol       Date:  2013-05-22       Impact factor: 3.064

2.  Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.

Authors:  Azza E El Bassiouny; Mona M Nosseir; Mona K Zoheiry; Noha A Ameen; Ahmed M Abdel-Hadi; Ibrahim M Ibrahim; Suher Zada; Abdel-Hakeem Saad El-Deen; Nora E El-Bassiouni
Journal:  World J Hepatol       Date:  2010-01-27

Review 3.  Serum tumor markers for detection of hepatocellular carcinoma.

Authors:  Lin Zhou; Jia Liu; Feng Luo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

4.  Cytotoxic effect of silica nanoparticles against hepatocellular carcinoma cells through necroptosis induction.

Authors:  Yuexiang Niu; Engong Tang; Qingan Zhang
Journal:  Toxicol Res (Camb)       Date:  2019-11-20       Impact factor: 3.524

5.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

6.  Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.

Authors:  Gokce Askan; Vikram Deshpande; David S Klimstra; Volkan Adsay; Carlie Sigel; Jinru Shia; Olca Basturk
Journal:  Am J Clin Pathol       Date:  2016-07-17       Impact factor: 2.493

7.  Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.

Authors:  Hong Seok Jang; Ki Mun Kang; Byung Ock Choi; Gyu Young Chai; Soon Chan Hong; Woo Song Ha; Randy L Jirtle
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

8.  Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.

Authors:  Gehan H Ibrahim; Moushira A Mahmoud; Nagwa M Aly
Journal:  Mol Biol Rep       Date:  2013-11-02       Impact factor: 2.316

9.  The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.

Authors:  Lisa M Privette Vinnedge; Shuk-Mei Ho; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma.

Authors:  Asako Kimura; Kazuyuki Sogawa; Mamoru Satoh; Yoshio Kodera; Osamu Yokosuka; Takeshi Tomonaga; Fumio Nomura
Journal:  Int J Proteomics       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.